Los Angeles Capital Management
TELA icon

Los Angeles Capital Management’s TELA Bio TELA Stock Holding History

Los Angeles Capital Management’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-27,772
Closed -$131K – 1297
2024
Q2 		$131K Buy
+27,772
New +$146K ﹤0.01% 1148

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Los Angeles Capital Management's TELA Position: Q3 2024 in Review

Los Angeles Capital Management sold out of TELA Bio (TELA) in Q3 2024, closing a stake of 27,772 shares — an estimated $131K sold.

Los Angeles Capital Management first reported a position in TELA in Q2 2024 and held it in 1 quarter. The position peaked at $131K in Q2 2024. 49 funds tracked by Wall St. Rank hold TELA as of Q3 2024.

  • Los Angeles Capital Management reported no remaining TELA Bio position as of Q3 2024 after selling out during the quarter.
  • Los Angeles Capital Management sold 27,772 TELA Bio shares in Q3 2024, an estimated $131K.
  • Los Angeles Capital Management first reported a position in TELA Bio in Q2 2024 and held it in 1 quarter.
  • Los Angeles Capital Management's TELA Bio position peaked at $131K in Q2 2024.
  • 49 funds tracked by Wall St. Rank held TELA Bio as of Q3 2024.

Based on Los Angeles Capital Management's 13F filing for Q3 2024, filed 4 Nov 2024.